25 Nov

Relocation of head office

Atomo Diagnostics Limited ACN 142 925 684 Level 2, 701 – 703 Parramatta Road, Leichhardt NSW 2040 Australia ASX Announcement 2 5 November 202 1 Relocation of head office SYDNEY Australia Thursday, 2 5 November 2021 – Atomo Diagnostics Limited (ASX: AT1) ( Atomo ) advises of the relocation of its head office. Th e relocation from the current office will be effective on Wednesday, 1 December 2021 . From 1 December 2021, t he Company’s registered office address and principal place of business will be : Level 1, 3 - 5 George Street Leichhardt NSW 2040 Ph +61 (0)2 9099 4750 (unchanged) For more information, please contact: Jane Lowe John Kelly IR Department Atomo Diagnostics jane.lowe@irdepartment.com.au john.kelly@atomodiagnostics.com Phone: +61 411 117 774 Phone: +61 401 922 279 This announcement was authorised by the Managing Director. About Atomo Atomo is an Australian medical device company supplying unique, integrated rapid diagnostic test (RDT) devices to the global diagnostic market. Atomo’s patented devices simplify testing procedures and enhance usability for professional users and untrained self - testers. The Company has supply agreements in place for tests targeting infectious diseases including COVID - 19, HIV, viral vs bacterial differentiation and female health. See more at www.atomodiagnostics.com .
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Atomo Diagnostics Limited (ASX:AT1) when you join Listcorp.